
A New Breast Cancer Prognostic Signature Identifies the Genes Tumours Need to Survive
Researchers used CRISPR gene-editing to identify the essential genes breast cancer cells require to stay alive. The resulting nine-gene model predicts patient outcomes more accurately than traditional clinical methods.






